Abstract
The screening of large libraries in order to obtain hits for receptors of interest has been the mainstay of drug research for some time now. It is increasingly being recognised that this is a relatively inefficient way to achieve this end and the screening of libraries either designed or selected to hit particular targets is rapidly becoming the method of choice. The advantages in terms of success rate to achieve viable lead series are magnified by the cost and time savings achieved by screening more carefully selected groups of compounds. A number of approaches have been used for the design and production of such libraries or methods for selection of such focused sets from larger diverse collections. These range from combinatorially produced ligand-mimetic approaches through pharmacophore-based design to those methods based on statistical selection techniques. Most recently, progress in chemogenomic approaches has thrown new light on the relationship between receptor sequence and compounds that interact at particular receptors and this is also having an impact on the design of targeted libraries.
Keywords: G-Protein Coupled, chemogenomic
Current Topics in Medicinal Chemistry
Title: The Design of Screening Libraries Targeted at G-Protein Coupled Receptors
Volume: 4 Issue: 6
Author(s): Roger Crossley
Affiliation:
Keywords: G-Protein Coupled, chemogenomic
Abstract: The screening of large libraries in order to obtain hits for receptors of interest has been the mainstay of drug research for some time now. It is increasingly being recognised that this is a relatively inefficient way to achieve this end and the screening of libraries either designed or selected to hit particular targets is rapidly becoming the method of choice. The advantages in terms of success rate to achieve viable lead series are magnified by the cost and time savings achieved by screening more carefully selected groups of compounds. A number of approaches have been used for the design and production of such libraries or methods for selection of such focused sets from larger diverse collections. These range from combinatorially produced ligand-mimetic approaches through pharmacophore-based design to those methods based on statistical selection techniques. Most recently, progress in chemogenomic approaches has thrown new light on the relationship between receptor sequence and compounds that interact at particular receptors and this is also having an impact on the design of targeted libraries.
Export Options
About this article
Cite this article as:
Crossley Roger, The Design of Screening Libraries Targeted at G-Protein Coupled Receptors, Current Topics in Medicinal Chemistry 2004; 4 (6) . https://dx.doi.org/10.2174/1568026043451140
DOI https://dx.doi.org/10.2174/1568026043451140 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of <i>Umbelliprenin</i> on Antinociceptive Activity of Morphine in a Rat Model of Neuropathic Pain Induced by Chronic Constriction Injury of the Sciatic Nerve
The Natural Products Journal Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Current Drug Targets Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Bubble Electrospinning: Patents, Promises and Challenges
Recent Patents on Nanotechnology Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease
Letters in Drug Design & Discovery NF-κB Links Keratinocytes and Lymphocytes in the Pathogenesis of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design Therapeutic Potential of Drugs Targeting Pathophysiology of Intracerebral Hemorrhage: From Animal Models to Clinical Applications
Current Pharmaceutical Design Controversial Effects of Non-Steroidal Anti-Inflammatory Drugs on Bone: A Review
Inflammation & Allergy - Drug Targets (Discontinued) High Sensitivity C-Reactive Protein (hsCRP): A New Biochemical Marker of Atherosclerotic Vascular Disease
Current Cardiology Reviews The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive Illness in the Elderly
Current Neuropharmacology Medical Treatment of Critical Limb Ischemia: Current State and Future Directions
Current Vascular Pharmacology Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in Taiwan
Current Alzheimer Research Phytochemicals as Adjunctive with Conventional Anticancer Therapies
Current Pharmaceutical Design Part II: Targeted Particles for Imaging of Anticancer Immune Responses
Current Drug Delivery Inflammatory Mechanisms in Myocardial Infarction
Current Drug Targets - Inflammation & Allergy Apoptosis-Inducing Effects of Amaryllidaceae Alkaloids
Current Medicinal Chemistry Chemical and Bioactive Diversities of the Genus Chaetomium Secondary Metabolites
Mini-Reviews in Medicinal Chemistry From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Current Pharmaceutical Design